NCT03065478View on ClinicalTrials.gov

Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy

CompletedOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

November 22, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions

CIPN in Adjuvant Colon Cancer PatientsCIPN in Adjuvant Breast Cancer Patients

Interventions

DIETARY_SUPPLEMENT

OnLife

Daily dosing of dietary supplement OnLife

Trial Locations (1)

79110

Praxis für interdisziplinäre Onkologie & Hämatologie, Freiburg im Breisgau

All Listed Sponsors

collaborator

iOMEDICO AG

INDUSTRY

lead

Swiss Medical Food AG

INDUSTRY

NCT03065478 - Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy | Biotech Hunter | Biotech Hunter